Share price and RNS

To view the latest share price data and regulatory news service announcements for Sareum plc please click on the links below.

Sareum Holdings News and Articles from

Proactive Investors logo

News - Sareum raises £680k as it looks to take its TYK2/JAK1 inhibitors into the clinic next year
26th June 2019
Sareum Holdings PLC (LON:SAR) has raised £681,000 which it will use to advance its TYK2/JAK1 inhibitor programme towards human trials. The drug developer sold 170.37mln new shares at 0.4p as part of the fundraising, which was carried out on t…
RNS press release - Successful Fundraising
26th June 2019
RNS press release - PrimaryBid.com Offer
25th June 2019
RNS press release - Placing to progress TYK2/JAK1 programmes
25th June 2019
News - Sareum surges as it signals progress on pre-clinical programmes
13th June 2019
Sareum Holdings PLC (LON:SAR), the specialist small molecule drug development business, has hailed the recent progress of its clinical and pre-clinical programmes. Following last week’s announcement of preliminary efficacy data for SRA737, a …
50

  • @Sareumplc Latest tweet

    RT @JebKeiper: Tyk2 is what this is all about $BMY. Game changing new MOA: the tykinibs are reshaping immunology, first by upending the pso… via @Sareumplc
    View more

Contact

Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge CB22 3FX
United Kingdom


tel: +44 (0) 1223 497700
fax: +44 (0) 1223 497701
email_white.png

Downloads

Yearly Results 2018     Notice of AGM 2018

Annual Report 2018  AGM Votes 2018    

Results 2018  Annual Report 2018